Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Trends Genet. 2024 Jun;40(6):471-479. doi: 10.1016/j.tig.2024.04.001. Epub 2024 Apr 19.
Enhancers are the key regulators of other DNA-based processes by virtue of their unique ability to generate nucleosome-depleted regions in a highly regulated manner. Enhancers regulate cell-type-specific transcription of tRNA genes by RNA polymerase III (Pol III). They are also responsible for the binding of the origin replication complex (ORC) to DNA replication origins, thereby regulating origin utilization, replication timing, and replication-dependent chromosome breaks. Additionally, enhancers regulate V(D)J recombination by increasing access of the recombination-activating gene (RAG) recombinase to target sites and by generating non-coding enhancer RNAs and localized regions of trimethylated histone H3-K4 recognized by the RAG2 PHD domain. Thus, enhancers represent the first step in decoding the genome, and hence they regulate biological processes that, unlike RNA polymerase II (Pol II) transcription, do not have dedicated regulatory proteins.
增强子是其他基于 DNA 的过程的关键调节剂,其独特的能力是以高度调控的方式产生核小体缺失区域。增强子通过 RNA 聚合酶 III(Pol III)调节 tRNA 基因的细胞类型特异性转录。它们还负责将起始复制复合物(ORC)结合到 DNA 复制起点,从而调节起点利用、复制时间和复制依赖性染色体断裂。此外,增强子通过增加重组激活基因(RAG)重组酶对靶位点的可及性,并通过产生非编码增强子 RNA 和被 RAG2 PHD 结构域识别的局部区域的三甲基化组蛋白 H3-K4,来调节 V(D)J 重组。因此,增强子代表了解码基因组的第一步,因此它们调节生物过程,这些过程与 RNA 聚合酶 II(Pol II)转录不同,没有专门的调节蛋白。